Evidence map›Paper›PMID 19625651›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression.

Kyung-Hyun Park-Min, Jong-Dae Ji, Taras Antoniv, Alicia C Reid, Randi B Silver, Mary Beth Humphrey, Mary Nakamura, Lionel B Ivashkiv

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 120 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Effects ofJournal of Taibah University Medical Sciences · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Role of nitric oxide in orthodontic tooth movement (Review).International journal of molecular medicine · 2021
    Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Kyung-Hyun Park-MinArthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021, USA.
Jong-Dae Ji
Taras Antoniv
Alicia C Reid
Randi B Silver
Mary Beth Humphrey
Mary Nakamura
Lionel B Ivashkiv
Hospital for Special Surgery · USCornell University · USKorea University · KRUniversity of California, San Francisco · USUniversity of Oklahoma Health Sciences Center · US

Funding

CYTOKINE REGULATION OF RA SYNOVIOCYTE PHENOTYPER01AR046713 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI IVASHKIV, LIONEL B · 1999 to 2025
$8.3M
Negative Regulation of OsteoclastogenesisR01DE019420 · NIDCR · HOSPITAL FOR SPECIAL SURGERY · PI IVASHKIV, LIONEL B · 2008 to 2022
$6.0M
Ang II and Norepinephrine in Cardiac Sympathetic NervesR01HL073400 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEVI, ROBERTO · 2005 to 2009
$2.3M
Mechanism of ITAM Signal Regulation in OsteoclastsR01DE019398 · NIDCR · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI HUMPHREY, MARY BETH · 2008 to 2012
$1.3M
NHLBI NIH HHS HL073400NHLBI NIH HHS R01 HL073400NIAMS NIH HHS AR046713NIAMS NIH HHS R01 AR046713NIDCR NIH HHS DE019420NIDCR NIH HHS R01 DE019398NIDCR NIH HHS R01 DE019420
6 · The paper itself

Abstract

Induction of effective osteoclastogenesis by RANK (receptor activator of NF-kappaB) requires costimulation by ITAM-coupled receptors. In humans, the TREM-2 (triggering receptor expressed on myeloid cells 2) ITAM-coupled receptor plays a key role in bone remodeling, as patients with TREM-2 mutations exhibit defective osteoclastogenesis and bone lesions. We have identified a new rapidly induced costimulatory pathway for RANK signaling that is dependent on TREM-2 and mediated by calcium signaling. TREM-2-dependent calcium signals are required for RANK-mediated activation of calcium/calmodulin-dependent protein kinase (CaMK)II and downstream MEK and ERK MAPKs that are important for osteoclastogenesis. IL-10 inhibited RANK-induced osteoclastogenesis and selectively inhibited calcium signaling downstream of RANK by inhibiting transcription of TREM-2. Down-regulation of TREM-2 expression resulted in diminished RANKL-induced activation of the CaMK-MEK-ERK pathway and decreased expression of the master regulator of osteoclastogenesis NFATc1. These findings provide a new mechanism of inhibition of human osteoclast differentiation. The results also yield insights into crosstalk between ITAM-coupled receptors and heterologous receptors such as RANK, and they identify a mechanism by which IL-10 can suppress cellular responses to TNFR family members.

Indexed as

AnimalsCalciumCell DifferentiationCells, CulturedGrowth InhibitorsHumansInterleukin-10MiceOsteoclastsReceptor Activator of Nuclear Factor-kappa BReceptor Cross-TalkReceptors, ImmunologicSignal TransductionTranscription, GeneticCalciumGrowth InhibitorsIL10 protein, humanInterleukin-10Receptor Activator of Nuclear Factor-kappa BReceptors, ImmunologicTREML2 protein, human

Identifiers

PMID19625651
PMCPMC2742169
OpenAlexW1976732545

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.